“Efficacy and Safety of Dapagliflozin As Adjunct Therapy in Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea”. Academia Journal of Medicine 9, no. 2 (October 23, 2026): 201–205. Accessed October 25, 2026. https://medjournal.co.in/index.php/ajm/article/view/358.